Next Lesson - Innate Immunity
Contents
Abstract
- Biofilms are a way in which bacteria arrange themselves to be able to stick to surfaces and survive in adverse environments. This is done by forming an encapsulating slimy extracellular matrix made of extracellular polymeric substances (large molecules, such as polysaccharides, proteins and DNA, that the bacteria release around themselves).
- Clinically, bacteria often use biofilms to lodge themselves on indwelling devices (devices left inside the body, such as catheters and artificial joints). They also use biofilms to protect themselves from the immune system within the body.
- The management of biofilms focuses first on prevention, as established biofilms are much less susceptible to antibacterial treatment. Infections on prosthetic material (artificial joints and valves) often need the device to be removed or replaced as well as antibiotics.
Core
- Sensing the population density: the bacteria detect how many of them there are (that is, whether there are enough bacteria to carry out a process).
- A signal (an autoinducer) that the bacteria release and that builds up as the population grows. When it reaches a threshold concentration, a quorum (the critical number of bacteria needed) has been reached.
- A receptor on the bacteria that detects the signal.
- A switching mechanism that alters gene expression so that the bacteria carry out the process.

Diagram: The formation of Biofilms on a surface, showing each step in their formation
Biofilms are a major cause for concern in hospitals where they are responsible for a considerable share of healthcare-acquired infections. In hospital, biofilm infections are often iatrogenic (caused by medical care or treatment). Common routes include indwelling devices (devices left inside the body), mechanical ventilators, intravascular lines (tubes placed in blood vessels), urinary catheters, prosthetic heart valves or orthopaedic implants (such as joint replacements). Each gives bacteria a surface to stick to. Biofilms also cause infections that are not iatrogenic, such as chronic wounds and lung infection in cystic fibrosis. The issue is further compounded by the fact that many of these devices, for example ventilators, are used in critically unwell patients who are already more susceptible to infection. Many of the organisms responsible for infection are commensal bacteria (bacteria that normally live on us without harm). They live on the surface of the skin, in the upper respiratory tract, in the lower gastrointestinal tract or in the urogenital tract (the urinary and genital organs). If they are carried from their usual site to another part of the body, or a medical device gives them a way in, they can cause disease (become pathogenic). Two common examples are Staphylococcus epidermidis and Staphylococcus aureus. Other bacteria, such as Pseudomonas aeruginosa, also cause biofilm infections.
Let’s go through a few common examples worth knowing about:
Prosthetic valve endocarditis: a serious complication of cardiac valve replacement surgery is prosthetic valve endocarditis (PVE). Endocarditis is infection of the endocardium (the inner lining of the heart), and here it affects an artificial valve. Early PVE usually means within 1 year of surgery and late PVE means more than 1 year after, although some studies use 60 days as the cut-off for early PVE. The most likely causative organisms depend on when the infection starts relative to the operation:
Bacteria in biofilms also release virulence factors (molecules that help bacteria cause disease). As mentioned above, quorum sensing is the modulation of gene expression in response to changes in cell population density. Bacteria within the matrix produce signal molecules known as autoinducers (AI). These signals help to regulate virulence factors such as exotoxins (toxins released by bacteria). Biofilm bacteria also resist antibiotics in other ways, for example by making beta lactamases (enzymes that break down penicillin-type antibiotics), and the biofilm helps protect them from the immune system. Together, the signalling, the beta lactamases and the protection from the immune system make bacterial colonies more resilient to immune attacks and antibiotics.
The efficacy of antimicrobials to treat biofilms is limited because:
- Antimicrobials may penetrate the matrix poorly, because the matrix can hold them back.
- On a prosthetic joint, the biofilm sits on the surface of the implant, where antimicrobials given by mouth or into a vein often cannot reach a high enough concentration.
- Once the bacteria have switched to a slower metabolism, they divide less often, which makes antimicrobials that act on growing cells less effective.
Therefore prevention is key. Biofilm formation and persistence on indwelling devices can be reduced by using sterile equipment, hand hygiene and an aseptic technique (a way of working that keeps microbes away from the patient). This applies when inserting and caring for devices such as urinary catheters and vascular access devices (tubes placed in blood vessels). The same applies to any prosthetic material. If an infection is already established on prosthetic material, treatment often needs the device to be removed or replaced as well as antibiotics, because antibiotics alone struggle to clear the biofilm.
Patients with a suspected infection should have samples taken so the microorganism can be identified and tested for its antimicrobial susceptibility (which antimicrobials it responds to). This allows the most effective antimicrobial to be prescribed. For endocarditis the samples include blood cultures (blood samples grown in the laboratory to find the organism). For a prosthetic joint infection, joint fluid is sampled before surgery and three to five separate tissue samples are taken during it.
Edited by: Dr. Marcus Judgeand Dr. Ben Appleby
Quiz
- 9190


